MergerLoop
  • Home
  • All Deals
  • Newsletter
  • 20 Weeks In Report
Back to register

MergerLoop is a DDLoop project

Back to register
WA-10020

Apollo Capital / CuriaWA-10020

View on ACCC

Processing timeline

17

days

Filed

30 June 2026

Notification waiver determination published

Decision

17 July 2026Notification waiver determination published
Type
Waiver
Outcome
Approved
Stage
Waiver application
Status
Assessment completed

Parties

Acquirer(s)

Apollo Capital Management, L.P. Registration No. 4293091

Target(s) or Vendor(s)

UIC Parent Corporation Registration No. 6432344, Curia Global, Inc.

Other parties

Apollo Global Management, Inc.

Summary

Apollo Capital Management, L.P., an affiliate of Apollo Global Management, Inc., proposes an equity acquisition of a majority stake in UIC Parent Corporation and its subsidiary Curia Global, Inc. Curia is a US-headquartered global contract research, development and manufacturing organisation.

Acquisition details

Various corporate credit and asset-backed finance-focused funds managed by affiliates of Apollo Capital Management, L.P. ( Apollo Capital or the Apollo Capital Funds ) propose to indirectly acquire the majority of the equity of UIC Parent Corporation, its subsidiary Curia Global, Inc. and/or the subsidiaries of Curia Global (together, Curia ) (the Acquisition). Apollo Capital is a wholly-owned indirect subsidiary of Apollo Global Management, Inc. ( AGM , together with the indirect subsidiaries of AGM managing the investment funds, Apollo ). Apollo is a global alternative asset manager organised under the laws of the United States of America and headquartered in New York. As of 31 March 2026, Apollo had approximately US$1.03 trillion of assets under management. Examples of current investments include, inter alia, companies in education, insurance, financial services, and leisure businesses. Curia is a US-headquartered global contract research, development and manufacturing organisation. Curia has a range of solutions across the drug development spectrum, including in small molecule, generic active pharmaceutical ingredients, biologics, sterile drug product and analytical testing services.

Industry

Broad:Professional & Business Services

Decisions and key events

17 July 2026Notification waiver determination publishedAttachmentPDF140.2 KB

More Professional & Business Services deals

  • Expedia / CarTrawlerMN-90022 · Notification · Filed 20 July 2026
  • Syngenta Crop Protection and Dümmen Orange / Joint Venture FormationMN-01109 · Notification · Filed 17 July 2026
  • Acrow / Ausgroup Industrial ServicesMN-60025 · Notification · Filed 16 July 2026
  • UPM-Kymmene / Sappi joint ventureMN-30023 · Notification · Filed 16 July 2026
  • Parker-Hannifin / CIRCOR A&DMN-70026 · Notification · Filed 15 July 2026
  • Laundy / Woy Woy HotelMN-40029 · Notification · Filed 15 July 2026